Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-220690
Filing Date
2026-05-13
Accepted
2026-05-13 08:31:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d78974ddefa14a.htm DEFA14A 12449
2 GRAPHIC g78974g02g02.jpg GRAPHIC 298572
3 GRAPHIC g78974g03g03.jpg GRAPHIC 159763
  Complete submission text file 0001193125-26-220690.txt   644957
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41583 | Film No.: 26971063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)